FERRARA, Rosario
FERRARA, Rosario
Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out
2019-01-01 Proto, C.; Ferrara, R.; Signorelli, D.; Lo Russo, G.; Galli, G.; Imbimbo, M.; Prelaj, A.; Zilembo, N.; Ganzinelli, M.; Pallavicini, L. M.; De Simone, I.; Colombo, M. P.; Sica, A.; Torri, V.; Garassino, M. C.
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors
2019-01-01 Fuca, G.; Galli, G.; Poggi, M.; Lo Russo, G.; Proto, C.; Imbimbo, M.; Ferrara, R.; Zilembo, N.; Ganzinelli, M.; Sica, A.; Torri, V.; Colombo, M. P.; Vernieri, C.; Balsari, A.; De Braud, F.; Garassino, M. C.; Signorelli, D.
RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion
2023-01-01 Aldea, M.; Marinello, A.; Duruisseaux, M.; Zrafi, W.; Conci, N.; Massa, G.; Metro, G.; Monnet, I.; Gomez Iranzo, P.; Tabbo, F.; Bria, E.; Guisier, F.; Vasseur, D.; Lindsay, C. R.; Ponce-Aix, S.; Cousin, S.; Citarella, F.; Fallet, V.; Minatta, J. N.; Eisert, A.; de Saint Basile, H.; Audigier-Valette, C.; Mezquita, L.; Calles, A.; Mountzios, G.; Tagliamento, M.; Remon Masip, J.; Raimbourg, J.; Terrisse, S.; Russo, A.; Cortinovis, D.; Rochigneux, P.; Pinato, D. J.; Cortellini, A.; Leonce, C.; Gazzah, A.; Ghigna, M. -R.; Ferrara, R.; Dall'Olio, F. G.; Passiglia, F.; Ludovini, V.; Barlesi, F.; Felip, E.; Planchard, D.; Besse, B.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out | 1-gen-2019 | Proto, C.; Ferrara, R.; Signorelli, D.; Lo Russo, G.; Galli, G.; Imbimbo, M.; Prelaj, A.; Zilembo, N.; Ganzinelli, M.; Pallavicini, L. M.; De Simone, I.; Colombo, M. P.; Sica, A.; Torri, V.; Garassino, M. C. | |
| Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors | 1-gen-2019 | Fuca, G.; Galli, G.; Poggi, M.; Lo Russo, G.; Proto, C.; Imbimbo, M.; Ferrara, R.; Zilembo, N.; Ganzinelli, M.; Sica, A.; Torri, V.; Colombo, M. P.; Vernieri, C.; Balsari, A.; De Braud, F.; Garassino, M. C.; Signorelli, D. | |
| RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion | 1-gen-2023 | Aldea, M.; Marinello, A.; Duruisseaux, M.; Zrafi, W.; Conci, N.; Massa, G.; Metro, G.; Monnet, I.; Gomez Iranzo, P.; Tabbo, F.; Bria, E.; Guisier, F.; Vasseur, D.; Lindsay, C. R.; Ponce-Aix, S.; Cousin, S.; Citarella, F.; Fallet, V.; Minatta, J. N.; Eisert, A.; de Saint Basile, H.; Audigier-Valette, C.; Mezquita, L.; Calles, A.; Mountzios, G.; Tagliamento, M.; Remon Masip, J.; Raimbourg, J.; Terrisse, S.; Russo, A.; Cortinovis, D.; Rochigneux, P.; Pinato, D. J.; Cortellini, A.; Leonce, C.; Gazzah, A.; Ghigna, M. -R.; Ferrara, R.; Dall'Olio, F. G.; Passiglia, F.; Ludovini, V.; Barlesi, F.; Felip, E.; Planchard, D.; Besse, B. |